Epiregulin Is a Potent Pan-ErbB Ligand That Preferentially Activates Heterodimeric Receptor Complexes

作者: Maya Shelly , Ronit Pinkas-Kramarski , Bradley C. Guarino , Hadassa Waterman , Ling-Mei Wang

DOI: 10.1074/JBC.273.17.10496

关键词:

摘要: The ErbB signaling network consists of four transmembrane receptor tyrosine kinases and more than a dozen ligands sharing an epidermal growth factor (EGF) motif. multiplicity ErbB-specific is incompletely understood in terms signal specificity because all molecules through partially overlapping pathways. Here we addressed the action epiregulin, recently isolated ligand ErbB-1. By employing set factor-dependent cell lines engineered to express individual ErbBs or their combinations, found that epiregulin broadest EGF-like so far characterized: not only does it stimulate homodimers both ErbB-1 ErbB-4, also activates possible heterodimeric complexes. Consistent with its relaxed selectivity, binds various combinations affinity approximately 100-fold lower stringent including EGF. Nevertheless, epiregulin's upon most transmits potent mitogenic This remarkable discrepancy between binding bioactivity permitted by mechanism prevents down-regulation, results weak, but prolonged, state activation.

参考文章(63)
DJ Riese 2nd, Yamilee Bermingham, TM Van Raaij, Sharon Buckley, Greogry D Plowman, David F Stern, Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene. ,vol. 12, pp. 345- 353 ,(1996)
Devarajan Karunagaran, Y. Yarden, S. Lavi, Naili Liu, Duanzhi Wen, R. Pinkas-Kramarski, M. Marikovsky, ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene. ,vol. 10, pp. 1403- 1411 ,(1995)
Ronit Pinkas-Kramarski, Iris Alroy, Yosef Yarden, ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling. Journal of Mammary Gland Biology and Neoplasia. ,vol. 2, pp. 97- 107 ,(1997) , 10.1023/A:1026343528967
R Faure, G Baquiran, J.J. Bergeron, B.I. Posner, The dephosphorylation of insulin and epidermal growth factor receptors. Role of endosome-associated phosphotyrosine phosphatase(s). Journal of Biological Chemistry. ,vol. 267, pp. 11215- 11221 ,(1992) , 10.1016/S0021-9258(19)49898-0
H Kadowaki, T Kadowaki, A Cama, B Marcus-Samuels, A Rovira, C L Bevins, S I Taylor, Mutagenesis of lysine 460 in the human insulin receptor. Effects upon receptor recycling and cooperative interactions among binding sites. Journal of Biological Chemistry. ,vol. 265, pp. 21285- 21296 ,(1990) , 10.1016/S0021-9258(17)45358-0
D Karunagaran, G Levkowitz, E Tzahar, A Yayon, S Lavi, N Liu, D Wen, E Peles, L Yi, D Chang, ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. Journal of Biological Chemistry. ,vol. 269, pp. 25226- 25233 ,(1994) , 10.1016/S0021-9258(17)31521-1
Sarah S. Bacus, Yosef Yarden, Ilana Stancovski, Carolyn R. Zelnick, Michael Sela, Dot Chin, Duanzhi Wen, Andrei V. Gudkov, Elior Peles, Randi Stern, Ruth Lupu, Hannan Farbstein, Noa Ben-Baruch, Neu Differentiation Factor (Heregulin) Induces Expression of Intercellular Adhesion Molecule 1: Implications for Mammary Tumors Cancer Research. ,vol. 53, pp. 5251- 5261 ,(1993)
R. Pinkas-Kramarski, L. Soussan, H. Waterman, G. Levkowitz, I. Alroy, L. Klapper, S. Lavi, R. Seger, B. J. Ratzkin, M. Sela, Y. Yarden, Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. The EMBO Journal. ,vol. 15, pp. 2452- 2467 ,(1996) , 10.1002/J.1460-2075.1996.TB00603.X
D. Karunagaran, E. Tzahar, R. R. Beerli, X. Chen, D. Graus-Porta, B. J. Ratzkin, R. Seger, N. E. Hynes, Y. Yarden, ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer The EMBO Journal. ,vol. 15, pp. 254- 264 ,(1996) , 10.1002/J.1460-2075.1996.TB00356.X